62 studies found for:    Open Studies | "Opioid-Related Disorders"
Show Display Options
Rank Status Study
21 Not yet recruiting A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence
Condition: Opioid Dependence
Intervention: Other: Naturalistic Prospective Cohort
22 Not yet recruiting Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence
Condition: Opioid Addiction
Interventions: Other: FMRI;   Drug: Suboxone
23 Recruiting Study of Opioid Use After Lumbar Surgery
Conditions: Low Back Pain;   Opiate Addiction
Intervention: Behavioral: Educational Video
24 Not yet recruiting Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
Conditions: Opiate Addiction;   Pregnancy;   Contraceptive Behavior;   Sexual Behavior
Interventions: Drug: Nexplanon (etonogestrel contraceptive implant);   Drug: Standard postpartum contraceptive care
25 Not yet recruiting Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
Conditions: Opiate Dependence;   Sexually Transmitted Diseases;   HIV
Interventions: Behavioral: Acceptance and Commitment Therapy;   Behavioral: Information Motivation Behavioral Model
26 Recruiting Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments
Condition: Opiate Dependence
Interventions: Behavioral: Strengths-based Case Management (SBCM);   Behavioral: Screening, Assessment, and Referral (SAR)
27 Recruiting Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans
Condition: Opiate Addiction
Interventions: Drug: CBD 400 mg;   Drug: CBD 800 mg;   Drug: Control (placebo)
28 Not yet recruiting Comparing Opium Tincture (OT) With Methadone for Substitution Treatment of Opioid Dependence
Condition: Opioid Dependence
Interventions: Drug: opium;   Drug: methadone
29 Not yet recruiting The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention
Condition: Opiate Addiction
Intervention: Device: Suzhou Sceneray® DBS System
30 Recruiting Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence
Condition: Opioid Dependence
Interventions: Drug: CI-581;   Drug: Naltrexone titration and XR-NTX initiation
31 Not yet recruiting On-site Evaluation of Substances Consumption on Opiate Maintenance
Condition: Opiate Addiction
Interventions: Procedure: urine drug testing;   Other: no test
32 Recruiting Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
Condition: Opioid Dependence
Intervention: Drug: Buprenorphine/naloxone
33 Recruiting Study of Treatment for Opioid Dependence and Anxiety Disorders
Conditions: Anxiety Disorders;   Opiate Addiction
Interventions: Behavioral: I-CBT;   Behavioral: IDC
34 Not yet recruiting Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy
Conditions: Opiate Addiction;   Medication Non-adherence;   Addiction;   Opioid Dependence
Intervention: Device: AiCure monitoring and intervention
35 Recruiting Buprenorphine Treatment for Opioid Dependence
Condition: Opioid Dependence
Intervention: Drug: Buprenorphine
36 Unknown  Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program
Conditions: Opioid Dependence;   Opioid Use Disorder
Intervention: Other: Naloxone Education Intervention
37 Recruiting Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence
Condition: Opiate Dependence
Intervention: Drug: Oxytocin
38 Recruiting Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women
Conditions: Narcotic Addiction;   Neonatal Abstinence Syndrome
Interventions: Drug: Ondansetron;   Drug: Placebo
39 Recruiting Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction
Conditions: Alcohol Addiction;   Opiate Addiction
Interventions: Other: Delayed Intervention (DI);   Other: Rapid Intervention (RI)
40 Recruiting Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
Conditions: Opiate Dependence;   Human Immunodeficiency Virus
Interventions: Drug: injectable naltrexone;   Drug: placebo comparator

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years